Genprex Correlations

GNPX Stock

USD 1.79 0.07 3.76%

The current 90-days correlation between Genprex and InMed Pharmaceuticals is 0.11 (i.e., Average diversification). The correlation of Genprex is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak. If the correlation is 0, the equities are not correlated; they are entirely random.

Genprex Correlation With Market

Average diversification

The correlation between Genprex and DJI is 0.11 (i.e., Average diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Genprex and DJI in the same portfolio, assuming nothing else is changed.

Build AI portfolio with Genprex Stock

Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Genprex. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in inflation.

For more information on how to buy Genprex Stock please use our How to Invest in Genprex guide.

Moving together with Genprex Stock

0.71	RAC	Race Oncology	Pair Corr
0.62	AVH	Avita Medical	Pair Corr
0.73	VINC	Vincerx Pharma, Common	Pair Corr
0.62	VRAX	Virax Biolabs Group	Pair Corr

Moving against Genprex Stock

0.6	VCYT	Veracyte	Pair Corr
0.58	DSGN	Design Therapeutics	Pair Corr
0.5	VCEL	Vericel Corp Ord	Pair Corr
0.48	DNTH	Dianthus Therapeutics	Pair Corr
0.44	DVAX	Dynavax Technologies Trending	Pair Corr
0.4	0P6S	Bayer AG NA	Pair Corr
0.39	DMAC	DiaMedica Therapeutics	Pair Corr
0.34	DNLI	Denali Therapeutics	Pair Corr
0.32	VERA	Vera Therapeutics	Pair Corr
0.59	VTVT	vTv Therapeutics	Pair Corr
0.58	VRDN	Viridian Therapeutics	Pair Corr
0.42	VRTX	Vertex Pharmaceuticals	Pair Corr
0.38	ENTA	Enanta Pharmaceuticals	Pair Corr
0.33	VXRT	Vaxart Inc	Pair Corr

Related Correlations Analysis

	INM	LIMN	BDRX	CERO	JAGX	GRI	BIVI	CNSP	TOVX	CMMB
INM		0.88	0.79	0.84	0.96	0.57	0.92	0.87	0.82	0.81	INM
LIMN	0.88		0.63	0.82	0.88	0.61	0.82	0.71	0.7	0.68	LIMN
BDRX	0.79	0.63		0.64	0.76	0.48	0.84	0.85	0.73	0.82	BDRX
CERO	0.84	0.82	0.64		0.77	0.41	0.82	0.87	0.73	0.56	CERO
JAGX	0.96	0.88	0.76	0.77		0.55	0.87	0.81	0.81	0.8	JAGX
GRI	0.57	0.61	0.48	0.41	0.55		0.57	0.42	0.5	0.74	GRI
BIVI	0.92	0.82	0.84	0.82	0.87	0.57		0.89	0.79	0.83	BIVI
CNSP	0.87	0.71	0.85	0.87	0.81	0.42	0.89		0.81	0.77	CNSP
TOVX	0.82	0.7	0.73	0.73	0.81	0.5	0.79	0.81		0.74	TOVX
CMMB	0.81	0.68	0.82	0.56	0.8	0.74	0.83	0.77	0.74		CMMB
	INM	LIMN	BDRX	CERO	JAGX	GRI	BIVI	CNSP	TOVX	CMMB

Please upgrade your account to get full access to Macroaxis premium features

Risk-Adjusted Indicators

There is a big difference between Genprex Stock performing well and Genprex Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Genprex's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Treynor Ratio	Semi Deviation	Expected Shortfall	Potential Upside	Value @Risk	Maximum Drawdown
INM	4.08	(1.01)	(0.33)	0.00	0.00	7.50	(9.79)	30.84
LIMN	4.81	(1.38)	(0.56)	0.00	0.00	10.11	(10.59)	44.72
BDRX	10.26	(0.08)	0.01	13.70	(11.75)	35.98	(16.09)	128.35
CERO	11.26	(2.68)	(0.82)	0.00	0.00	20.60	(21.43)	115.30
JAGX	4.81	(0.91)	(1.02)	0.00	0.00	7.84	(11.85)	29.10
GRI	5.92	(2.33)	8.24	0.00	0.00	8.08	(12.50)	76.91
BIVI	2.98	(0.66)	(4.19)	0.00	0.00	6.62	(6.15)	17.43
CNSP	3.07	(0.56)	(0.71)	0.00	0.00	5.99	(6.36)	18.23
TOVX	7.93	(0.31)	(0.08)	0.00	0.00	17.24	(14.29)	139.72
CMMB	3.53	(0.46)	1.16	0.00	0.00	5.51	(7.69)	31.60

Genprex Corporate Management

CMA CPA	Co Controller	Profile
Celina Laney	Chief Staff	Profile
David Schloss	Senior Resources	Profile
William Gannon	Member Affairs	Profile
CPM EMBA	Chief Officer	Profile
Kalyn Dabbs	Sr Marketing	Profile

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2025 Macroaxis LLC